New York Life Investment Management LLC Madrigal Pharmaceuticals, Inc. Transaction History
New York Life Investment Management LLC
- $9.26 Billion
- Q1 2025
A detailed history of New York Life Investment Management LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, New York Life Investment Management LLC holds 1,665 shares of MDGL stock, worth $452,164. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,665Holding current value
$452,164% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
366Shares Held
23.3MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$599 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$570 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$549 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$541 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$536 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.64B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...